Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-17 Purchase | 2023-05-18 2:13 pm | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 5,000 | $3.7263 | $18,632 | 112,746 (Direct) | View |
| 2022-09-16 Purchase | 2022-09-19 07:00 am | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 31,746 | $3.15 | $100,000 | 31,746 (Direct) | View |
| 2022-08-12 Purchase | 2022-08-16 4:01 pm | ORASURE TECHNOLOGIES INC | OSUR | Celano Michael Director | 12,000 | $4.493 | $53,916 | 111,823 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-17 Option Award | 2024-01-19 4:32 pm | N/A 2034-01-17 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 218,750 | $0 | 331,496 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:16 pm | N/A 2033-01-31 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 196,000 | $0 | 227,746 (Direct) | View |
| 2022-05-16 Tax Withholding | 2022-05-18 4:06 pm | N/A N/A | ORASURE TECHNOLOGIES INC | OSUR | Celano Michael Director | 3,399 | $5.25 | 99,823 (Direct) | View |
| 2022-05-16 Option Award | 2022-05-18 4:06 pm | N/A N/A | ORASURE TECHNOLOGIES INC | OSUR | Celano Michael Director | 24,762 | $5.25 | 99,823 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 8:28 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 7:19 pm | N/A 2032-01-18 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-05-17 Tax Withholding | 2021-05-19 4:05 pm | N/A N/A | ORASURE TECHNOLOGIES INC | OSUR | Celano Michael Director Director | 2,041 | $9.5012 | 78,460 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-19 4:05 pm | N/A N/A | ORASURE TECHNOLOGIES INC | OSUR | Celano Michael Director Director | 13,559 | $9.5875 | 78,460 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-21 10:55 am | N/A 2031-01-19 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 42,000 | $0 | 42,000 (Direct) | View |
| 2020-09-29 Option Award | 2020-09-30 2:05 pm | N/A 2030-07-16 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 84,100 | $0 | 84,100 (Direct) | View |
| 2020-05-28 Option Award | 2020-06-05 8:04 pm | N/A 2030-05-28 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 60,479 | $0 | 60,479 (Direct) | View |
| 2020-05-15 Tax Withholding | 2020-05-19 4:37 pm | N/A N/A | ORASURE TECHNOLOGIES INC | OSUR | Celano Michael Director Director | 3,843 | $16.04 | 66,942 (Direct) | View |
| 2020-05-18 Option Award | 2020-05-19 4:37 pm | N/A N/A | ORASURE TECHNOLOGIES INC | OSUR | Celano Michael Director Director | 8,143 | $15.96 | 66,942 (Direct) | View |